Tang Capital Management Llc - Oct 2, 2025 SCHEDULE 13G Report for Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share (CBIO)

Filing Manager
TANG CAPITAL MANAGEMENT LLC
Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Security
Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share
Symbol
CBIO
Shares outstanding
13.9M shares
Disclosed Ownership
700K shares
Ownership
5.04%
Form type
SCHEDULE 13G
Date filed
10/9/2025, 04:15 PM
Date of event
Oct 2, 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 5.04% 700K 0 700K /s/ Kevin Tang Manager
KEVIN TANG 5.04% 700K 0 700K /s/ Kevin Tang Self
TANG CAPITAL PARTNERS, LP 2.84% 394K 0 394K /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP 2.2% 306K 0 306K /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer